ELFABRIO FDA approval date

The FDA approved ELFABRIO on 9 May 2023.

FDA approval date
9 May 2023

Drug identity has not yet been verified against registry records

Also recorded as PEGUNIGALSIDASE ALFA-IWXJ

Included trials

No linked trials for this drug yet. Browse all trials

PDUFA dates and FDA decisions

Date as reportedDrug / companyEventConditionEvidence
2023-05-09DayELFABRIOFDA original application approvalFDA approval decisionNot specifiedOpen original source
Read source excerpt

{"application_number": "BLA761161", "applicant_as_listed_by_fda": "CHIESI FARMACEUTICI SPA", "brand_names": ["ELFABRIO"], "active_ingredients": ["PEGUNIGALSIDASE ALFA-IWXJ"], "submission_type": "ORIG", "submission_number": "1", "submission_status": "AP", "submission_status_date": "20230509", "matched_on": "drug record created from this FDA brand name"}

First seen: 06 Oct 2026 · Evidence last checked: 06 Oct 2026